Knight Therapeutics Competitors and Similar CompaniesClear all

Knight Therapeutics's competitors and similar companies include Nivagen Pharmaceuticals, bene-Arzneimittel, Accord Healthcare and Yabao Pharmaceutical.

	Knight Therapeutics Knight Therapeutics is a specialty pharmaceutical company focused on acquiring, in-licensing, selling, and marketing prescription and over-the-counter pharmaceutical products.	Nivagen Pharmaceuticals Nivagen Pharmaceuticals is a company specializing in the development, acquisition, and sales of generic prescription drugs.	bene-Arzneimittel bene-Arzneimittel is a pharmaceutical company focused on analgesic, pediatric, and urological medicines.	Accord Healthcare Accord Healthcare is a company that develops, manufactures, and distributes pharmaceutical products.	Yabao Pharmaceutical Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines.
Founding Date	Founding Date 2014	Founding Date 2009	Founding Date 1949	Founding Date N/A	Founding Date 1978
Type	Type Public	Type Private	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech distribution drug development pharma	Tags Healthcare biotech distribution drug development pharma	Tags Healthcare biotech distribution drug development pharma	Tags Healthcare biotech distribution drug development pharma	Tags Healthcare biotech distribution drug development pharma
Locations	Locations Westmount, CA HQ	Locations Sacramento, US HQ	Locations München, DE HQ Olching, DE	Locations Ahmedabad, IN HQ Melbourne, AU Salzburg, AT Salzburg, AT Aalst, BE Bruxelles, BE see more	Locations Yuncheng Shi, CN HQ Beijing, CN Yuncheng, CN Yuncheng Shi, CN
Employees	Employees 745	Employees 885% increase	Employees 67	Employees 1,971	Employees 3,611
Valuation ($)	Valuation ($) 410.4 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 613.8 m
Financial
Revenue (est.)	Revenue (est.) $450.1m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥2.2b (FY, 2025)
Cost of goods	Cost of goods $249.9m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥1.1b (FY, 2025)
Gross profit	Gross profit $200.2m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥1.1b (FY, 2025)
Net income	Net income ($5.4m) (FY, 2025)	Net income N/A	Net income N/A	Net income N/A	Net income ¥299.9m (FY, 2025)
Funding
Total funding raised	Total funding raised $ 180m	Total funding raised $ 26m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A